Compare CMPS & EVAC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CMPS | EVAC |
|---|---|---|
| Founded | 2020 | 2024 |
| Country | United Kingdom | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Fluid Controls |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 724.5M | 590.3M |
| IPO Year | 2020 | N/A |
| Metric | CMPS | EVAC |
|---|---|---|
| Price | $5.76 | $10.11 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 7 | 0 |
| Target Price | ★ $26.57 | N/A |
| AVG Volume (30 Days) | ★ 1.8M | 24.6K |
| Earning Date | 05-07-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $2.25 | $9.90 |
| 52 Week High | $8.90 | $10.17 |
| Indicator | CMPS | EVAC |
|---|---|---|
| Relative Strength Index (RSI) | 46.59 | 56.65 |
| Support Level | $4.90 | $9.99 |
| Resistance Level | $7.02 | $10.11 |
| Average True Range (ATR) | 0.28 | 0.01 |
| MACD | 0.07 | 0.00 |
| Stochastic Oscillator | 71.76 | 87.50 |
Compass Pathways PLC is a biotechnology company focused on developing therapies for mental health conditions. Its research centers on a proprietary synthetic psilocybin formulation, COMP360, which is administered alongside psychological support. The company is conducting clinical trials to evaluate the safety and efficacy of this treatment in patients with treatment-resistant depression and other mental health disorders. The company operates in one operating segment.
EQV Ventures Acquisition Corp II is a blank check company.